Kamat K, Inamdar M. Generation of OCIAD2 homozygous knockout (BJNhem20-OCIAD2-CRISPR-33) and heterozygous knockout (BJNhem20-OCIAD2-CRISPR-40) human embryonic stem cell lines using CRISPR-Cas9 mediated targeting. Stem Cell Res. 2023;67:103026 pubmed publisher

White J, Thompson D, Koch K, Kiriazov B, Beck A, van der Heide D, et al. AP-2alpha-mediated activation of E2F and EZH2 drives melanoma metastasis. Cancer Res. 2021;: pubmed publisher

Keen K, Petersen A, Figueroa A, Fordyce B, Shin J, Yadav R, et al. Physiological Characterization and Transcriptomic Properties of GnRH Neurons Derived From Human Stem Cells. Endocrinology. 2021;162: pubmed publisher

Jansen E, van Bakel N, Benedict B, Olde Loohuis N, Hafmans T, Chim S, et al. Novel vertebrate- and brain-specific driver of neuronal outgrowth. Prog Neurobiol. 2021;202:102069 pubmed publisher

Beck A, Cho E, White J, Paemka L, Li T, Gu V, et al. AP-2α Regulates S-Phase and Is a Marker for Sensitivity to PI3K Inhibitor Buparlisib in Colon Cancer. Mol Cancer Res. 2021;19:1156-1167 pubmed publisher

Jackson M, Fidanza A, Taylor A, Rybtsov S, Axton R, Kydonaki M, et al. Modulation of APLNR Signaling Is Required during the Development and Maintenance of the Hematopoietic System. Stem Cell Reports. 2021;16:727-740 pubmed publisher

Fontana D, Mauri M, Renso R, Docci M, Crespiatico I, Røst L, et al. ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine. Nat Commun. 2020;11:5938 pubmed publisher

Xiong M, Tao Y, Gao Q, Feng B, Yan W, Zhou Y, et al. Human Stem Cell-Derived Neurons Repair Circuits and Restore Neural Function. Cell Stem Cell. 2021;28:112-126.e6 pubmed publisher

Cardenas Diaz F, Osorio Quintero C, Diaz Miranda M, Kishore S, LEAVENS K, Jobaliya C, et al. Modeling Monogenic Diabetes using Human ESCs Reveals Developmental and Metabolic Deficiencies Caused by Mutations in HNF1A. Cell Stem Cell. 2019;25:273-289.e5 pubmed publisher

Zaslavsky K, Zhang W, McCready F, Rodrigues D, Deneault E, Loo C, et al. SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons. Nat Neurosci. 2019;22:556-564 pubmed publisher

Woodbury Smith M, Deneault E, Yuen R, Walker S, Zarrei M, Pellecchia G, et al. Mutations in RAB39B in individuals with intellectual disability, autism spectrum disorder, and macrocephaly. Mol Autism. 2017;8:59 pubmed publisher

Lee J, Krivega I, Dale R, Dean A. The LDB1 Complex Co-opts CTCF for Erythroid Lineage-Specific Long-Range Enhancer Interactions. Cell Rep. 2017;19:2490-2502 pubmed publisher

Lai F, Lau S, Wong J, Gui H, Wang R, Zhou T, et al. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function. Gastroenterology. 2017;153:139-153.e8 pubmed publisher

Bressan R, Dewari P, Kalantzaki M, Gangoso E, Matjusaitis M, Garcia Diaz C, et al. Efficient CRISPR/Cas9-assisted gene targeting enables rapid and precise genetic manipulation of mammalian neural stem cells. Development. 2017;144:635-648 pubmed publisher

Shetty D, Inamdar M. Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-39. Stem Cell Res. 2016;16:308-10 pubmed publisher

Courtney D, Moore J, Atkinson S, Maurizi E, Allen E, Pedrioli D, et al. CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting. Gene Ther. 2016;23:108-12 pubmed publisher

Chen Y, Cao J, Xiong M, Petersen A, Dong Y, Tao Y, et al. Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9. Cell Stem Cell. 2015;17:233-44 pubmed publisher

Ding Q, Regan S, Xia Y, Oostrom L, Cowan C, Musunuru K. Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell. 2013;12:393-4 pubmed publisher